AXIM BIOTECHNOLOGIES, INC. Derivative Liability, Current
AXIM BIOTECHNOLOGIES, INC. (AXIM) had Derivative Liability, Current of $4.12 million as of 2024-06-30, per its 10-Q filed 2024-08-19.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DerivativeLiabilitiesCurrent · last filed 2024-08-19
- 2024-06-30: Derivative Liability, Current $4.12M.
- 2024-03-31: Derivative Liability, Current $2.49M.
- 2023-12-31: Derivative Liability, Current $2.48M.
- 2023-09-30: Derivative Liability, Current $2.37M.
| Period end | Derivative Liability, Current |
|---|---|
| 2024-06-30 | $4.12M 10-Q · filed 2024-08-19 |
| 2024-03-31 | $2.49M 10-Q/A · filed 2024-05-22 |
| 2023-12-31 | $2.48M 10-Q · filed 2024-08-19 |
| 2023-09-30 | $2.37M 10-Q · filed 2023-11-20 |
| 2023-06-30 | $6.65M 10-Q · filed 2023-08-21 |
| 2023-03-31 | $1.12M 10-Q · filed 2023-05-22 |
| 2022-12-31 | $1.65M 10-K · filed 2024-04-16 |
| 2021-12-31 | $0.00 10-K · filed 2023-04-17 |
| 2016-12-31 | $0.00 10-K · filed 2017-09-14 |
| 2016-09-30 | $1.06M 10-Q · filed 2016-11-30 |
| 2015-12-31 | $0.00 10-K · filed 2017-09-14 |